Trazodone for Sleep: Side Effects, Dosage, and the Long-Term Reality
Short answer: trazodone can cause drowsiness and may help some people sleep in the short term, but it is not FDA-approved as an insomnia medication. If you take it regularly for sleep, ask your clinician about side effects, next-day impairment, and whether CBT-I skills should be part of the plan.
Trazodone comes up constantly in sleep conversations because it is commonly prescribed off-label. Originally approved as an antidepressant, its sedating side effect is why many clinicians consider it for sleep. It is also not a controlled substance, which can make it feel simpler than some other sleep medications.
The tradeoff is that sedation can come with morning grogginess, dizziness, and a plan that still does not address the sleep patterns that keep chronic insomnia going.
What Trazodone Actually Does to Your Brain
Trazodone is a SARI — Serotonin Antagonist and Reuptake Inhibitor. At the high doses used for depression (150-600mg), it meaningfully boosts serotonin. But the sleep doses typically prescribed? 25-100mg. The drug has a completely different mechanism at that lower range.
At these low doses, trazodone primarily blocks two receptors: 5-HT2A (serotonin) and H1 (histamine). Essentially, it turns down your brain's wakefulness drive. That heavy, physical drowsiness hitting you 30-60 minutes after the pill is not natural sleep arriving. Instead, it is a chemical suppression of your arousal system.
This distinction matters for anyone trying to improve insomnia symptoms. Trazodone may lower arousal, but it does not by itself retrain the bedtime habits, worry loops, or irregular schedules that can keep insomnia active.
The Research Is Thinner Than You'd Expect
For all its popularity, the clinical data supporting trazodone for primary insomnia is surprisingly weak. Most foundational studies looked at patients who had depression and insomnia. If your insomnia is not caused by depression — and for a significant portion of the population, it isn't — the clinical benefits shrink considerably.
A major meta-analysis by Qaseem et al. (DOI: 10.7326/M15-2175) and a comprehensive 2024 review by Furukawa in JAMA Psychiatry (DOI: 10.1001/jamapsychiatry.2023.5060) put actual numbers on the efficacy: trazodone might shave 10-15 minutes off the time it takes to fall asleep. Total sleep time and nighttime awakenings? These metrics barely moved compared to targeted behavioral interventions like Cognitive Behavioral Therapy for Insomnia (CBT-I).
Saving ten to fifteen minutes of wakefulness in exchange for a drug hangover that lasts three hours into the morning is a tradeoff many eventually regret.
The "Trazodone Hangover" and Common Side Effects
Nobody stops trazodone because it works too well. They stop because of what happens the next morning. The half-life of trazodone is 5-9 hours. If you take it at midnight, the active drug is literally still circulating in your bloodstream when your 7 AM alarm goes off.
Morning Grogginess: Two to three hours of brain fog where you feel unplugged from your own body is the most common complaint. Dry Mouth and Dizziness: The drug's anticholinergic-like properties lead to dry mouth, and orthostatic hypotension (standing up too fast and feeling dizzy) is highly prevalent. For older adults, this presents a significant fall risk. Priapism: A rare but serious side effect involving prolonged, painful erections requiring emergency medical attention. It is critical to be aware of this risk, though many prescribers fail to mention it. REM Sleep Alteration: While less disruptive to sleep architecture than benzodiazepines, any chemical intervention reshapes the natural cycle.
Pros and Cons of Trazodone for Sleep
To provide a balanced view, here is a breakdown of what trazodone offers versus what it costs you in the long run:
Pros:
- Not a DEA-controlled substance (no addiction potential in the traditional sense).
- Generally safer than benzodiazepines or Z-drugs (like Ambien) for long-term use.
- Can be highly effective for acute, stress-induced insomnia over a period of 1-2 weeks.
- Inexpensive and widely covered by health insurance.
Cons:
- Severe morning hangover effect due to its 5-9 hour half-life.
- High risk of orthostatic hypotension and dizziness upon waking.
- Fails to address the root psychological and behavioral causes of chronic insomnia.
- Causes "rebound insomnia" when discontinued, trapping the patient in a cycle of dependence.
- Efficacy diminishes over time as the brain habituates to the histamine blockade.
Why CBT-I keeps coming up in insomnia guidelines
The American College of Physicians recommends CBT-I as the initial treatment for chronic insomnia, and AASM guidance emphasizes behavioral treatment before or alongside medication decisions. This does not mean trazodone is never appropriate. It means medication should not be the whole plan if insomnia is chronic.
If trazodone is a way to reduce arousal, CBT-I is the process of changing the patterns that tell your brain the bed is a place for wakefulness. Sleep restriction, stimulus control, and cognitive restructuring can help you practice a more consistent sleep rhythm while your clinician manages medication decisions.
Your brain does not build tolerance to behavioral techniques in the same way it may adapt to sedating medications. That is why CBT-I skills are worth discussing when trazodone helps only partially, creates morning impairment, or becomes something you feel unable to sleep without. The same logic applies if you tried supplements first: if melatonin stopped working and trazodone is the next suggestion, the sleep patterns underneath still deserve attention.
How Zomni Fits In
The historical barrier to CBT-I was access. Finding a certified sleep psychologist, waiting months for an appointment, and paying out of pocket is not feasible for many people. That bottleneck is why Zomni was created — making structured CBT-I-informed guidance easier to access through your phone.
If you are currently taking trazodone, do not change your dose without your prescribing clinician. Zomni can sit alongside that care as CBT-I-informed wellness support: sleep windows, stimulus control, cognitive restructuring, and weekly reflection based on your sleep data. The goal is not to shame anyone for using medication, but to add skills that make the overall sleep plan more resilient.
Frequently Asked Questions (FAQ)
Is trazodone addictive? Physiologically, it is not a controlled substance like Xanax or Valium, meaning it does not cause chemical addiction. However, psychological dependence is very real. Your brain begins to require the "ritual" of the pill to grant itself permission to sleep.
When should I take trazodone for sleep? Clinical guidelines suggest taking it 30-60 minutes before your planned bedtime. A light snack can aid absorption and mitigate the stomach upset that some patients experience.
Can I drink alcohol while taking trazodone? No. Mixing trazodone with alcohol exponentially amplifies central nervous system depression. This leads to severe dizziness, dangerous respiratory depression, and loss of motor coordination.
Does trazodone lose its effectiveness over time? Some people report that the sedative effect becomes less helpful over time. If that happens, ask your clinician whether the next step should include CBT-I, sleep scheduling, anxiety support, or a medication review rather than simply increasing the dose.
The Honest Bottom Line
Trazodone absolutely has a place in sleep medicine. It is highly effective for short-term crisis management, insomnia driven primarily by severe depression, or bridging the gap while you build better sleep hygiene habits.
But as a long-term strategy, relying for years on a nightly sedative that leaves you groggy may mean the underlying insomnia patterns are still untouched. A safer conversation is not "pill or no pill" — it is whether medication, CBT-I skills, and clinician follow-up are working together.
Medical Disclaimer: This article is provided for informational and educational purposes only and does not constitute medical advice. Zomni is a wellness application and is not intended to diagnose, treat, cure, or prevent any disease. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication taper. Never disregard professional medical advice or delay in seeking it because of something you have read in this article.
References
- Furukawa, T. A., et al. (2024). Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults: A Systematic Review and Component Network Meta-analysis. JAMA Psychiatry. DOI: 10.1001/jamapsychiatry.2023.5060
- Khosla, S., et al. (2018). Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. DOI: 10.5664/jcsm.7128
- Qaseem, A., et al. (2016). Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine. DOI: 10.7326/M15-2175




